Allogeneic blood transfusion and cancer recurrence: 20 years later

This publication has 34 references indexed in Scilit:

• Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies
  British Journal of Surgery, 1998
• Transfusion‐associated cancer recurrence and postoperative infection: meta‐analysis of randomized, controlled clinical trials
  Transfusion, 1996
• Perioperative blood transfusion and cancer recurrence: meta‐analysis for explanation
  Transfusion, 1995
• Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
  Journal of Clinical Oncology, 1994
• Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer
  The Lancet, 1994
• In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
  European Journal of Immunology, 1993
• Blood Transfusions and Prognosis in Colorectal Cancer
  New England Journal of Medicine, 1993
• Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins.
  Journal of Experimental Medicine, 1991
• Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
  Proceedings of the National Academy of Sciences, 1989
• RED BLOOD CELLS FOR CANCER PATIENTS
  The Lancet, 1981